Bard G2 IVC Filter Lawsuit Filed After Unsuccessful Surgery to Remove

A Florida woman has filed a product liability lawsuit against C.R. Bard, after doctors were unable to remove one of the medical device manufacturer’s inferior vena cava (IVC) filters that migrated into the vein leading to her kidneys. 

The complaint (PDF) was filed by Lessie Tillman in the U.S. District Court for the Middle District of Florida on March 1, alleging that the Bard G2 IVC filter is defective and unreasonably dangerous.

The Bard G2 is an inferior vena cava (IVC) filter used for individuals who may be at risk for a pulmonary embolism, but for whom an anticoagulant has been ineffective or is contraindicated. The small, spider-like device contains a number of legs or struts that extend out to catch blood clots that may break free elsewhere in the body, such as the deep veins of the legs.

Learn More About

IVC Filter Lawsuits

Design Problems with Certain IVC Filters Linked to Severe Injuries. Lawsuits Reviewed Nationwide.

Learn More About this Lawsuit See If You Qualify For Compensation

Tillman indicates that her doctors implanted a Bard G2 IVC filter in February 2008, and discovered in March 2009 that it had migrated to the left renal vein.

Doctors unsuccessfully attempted to surgically remove the IVC filter, so Tillman indicates that she has been left with permanent injuries and disability, as well as the need for ongoing medical monitoring to check on the Bard G2 Filter and make sure it does not further damage her surrounding anatomy.

According to allegations raised in the Bard G2 IVC filter lawsuit, the manufacturer failed to adequately research the product or provide warnings about the high rate of fracture, migration and perforation of the vena cava wall that may occur once it is implanted in the body.

The complaint charges C.R. Bard with negligence, failure to warn, design and manufacturing a defective medical device, breach of warranty and negligent misrepresentation.

Complications and Problems with Bard IVC Filters

Unlike traditional IVC filters, the Bard G2 filter was designed so that it can be removed once the threat of a pulmonary embolism has passed.  However, in many cases physicians have allow the devices to remain in place, which may increase the risk of complications with the IVC filter, where the struts may fracture, perforate the vena cava or allow the device to migrate to other areas of the body, such as the heart or lungs.

In recent years, a number of individuals have filed similar lawsuits over the Bard G2 filter, as well as the similar Bard Recovery filter, which is an earlier version.  The complaints allege that Bard failed to adequately warn about the risks associated with leaving the Recovery or G2 filters in place once the threat of a pulmonary embolism has passed.

A study published in August 2010 in the Archives of Internal Medicine found that the failure rate for the Bard G2 filter was about 12%. The Bard Recovery suffered from a much higher 25% failure rate.

Tillman’s lawsuit seeks both compensatory and punitive damages.

2 Comments

  • AmosJanuary 2, 2014 at 4:57 pm

    My wife had to have open heart surgery on 12/11/14 to remove a foreign object from her heart. A 1 1/2 in piece of the blood clot filter broke off , traveled throughu her vein and pierced her heart. She is not sure what to do at this point. She is concerned what may happen in the future. The filter was placed In 2007.

  • StephenJuly 29, 2013 at 4:30 pm

    So now I live in fear every day...

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted yesterday)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 3 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.